1. Home
  2. PHIN vs NEO Comparison

PHIN vs NEO Comparison

Compare PHIN & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PHINIA Inc.

PHIN

PHINIA Inc.

HOLD

Current Price

$68.52

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$12.92

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHIN
NEO
Founded
2023
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
PHIN
NEO
Price
$68.52
$12.92
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$60.80
$11.38
AVG Volume (30 Days)
441.8K
1.8M
Earning Date
02-12-2026
02-17-2026
Dividend Yield
1.56%
N/A
EPS Growth
N/A
N/A
EPS
2.18
N/A
Revenue
$3,427,000,000.00
$709,162,000.00
Revenue This Year
$3.03
$10.87
Revenue Next Year
$1.40
$9.84
P/E Ratio
$31.78
N/A
Revenue Growth
N/A
10.10
52 Week Low
$36.25
$4.72
52 Week High
$70.03
$16.18

Technical Indicators

Market Signals
Indicator
PHIN
NEO
Relative Strength Index (RSI) 75.56 60.93
Support Level $64.74 $11.93
Resistance Level $70.03 $13.74
Average True Range (ATR) 1.61 0.59
MACD 0.36 0.03
Stochastic Oscillator 83.84 64.30

Price Performance

Historical Comparison
PHIN
NEO

About PHIN PHINIA Inc.

Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, the company generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: